# Ocean Biomedical Inc. (OCEA)

Source: https://www.quantisnow.com/company/OCEA
Generated: 2026-11-18T04:13:14.044Z

- Ticker: OCEA
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2021
- SEC CIK: 0001869974

## Latest OCEA news and filings

- 2025-08-14 12:30 UTC [SEC Form NT 10-Q filed by Ocean Biomedical Inc.](https://www.quantisnow.com/insight/sec-form-nt-10-q-filed-by-ocean-biomedical-inc-6164729)
- 2025-08-08 19:52 UTC [SEC Form 25-NSE filed by Ocean Biomedical Inc.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-ocean-biomedical-inc-6156087)
- 2025-08-05 20:45 UTC [SEC Form 8-K] [Ocean Biomedical Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Leadership Update, Other Events](https://www.quantisnow.com/insight/ocean-biomedical-inc-filed-sec-form-8-k-notice-of-delisting-6147992)
- 2025-07-23 21:27 UTC [SEC Form 8-K] [Ocean Biomedical Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/ocean-biomedical-inc-filed-sec-form-8-k-notice-of-delisting-6130214)
- 2025-07-16 21:25 UTC [SEC Form 8-K] [Ocean Biomedical Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement](https://www.quantisnow.com/insight/ocean-biomedical-inc-filed-sec-form-8-k-termination-of-a-6122520)
- 2025-06-13 21:25 UTC [SEC Form 8-K] [Ocean Biomedical Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement](https://www.quantisnow.com/insight/ocean-biomedical-inc-filed-sec-form-8-k-termination-of-a-6086570)
- 2025-05-15 21:22 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Ocean Biomedical Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-ocean-biomedical-inc-6043724)
- 2025-04-29 20:45 UTC [SEC Form 10-K] [Amendment: SEC Form 10-K/A filed by Ocean Biomedical Inc.](https://www.quantisnow.com/insight/amendment-sec-form-10-ka-filed-by-ocean-biomedical-inc-6007805)
- 2025-04-23 13:15 UTC [SEC Form 8-K] [Ocean Biomedical Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Leadership Update, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/ocean-biomedical-inc-filed-sec-form-8-k-notice-of-delisting-5997658)
- 2025-04-22 12:00 UTC [Ocean Biomedical Expands into Energy and Digital Asset Sectors to Accelerate Growth and Shareholder Value](https://www.quantisnow.com/insight/ocean-biomedical-expands-into-energy-and-digital-asset-sectors-to-5995679)
- 2025-04-08 14:11 UTC [SEC Form 10-K] [SEC Form 10-K filed by Ocean Biomedical Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-ocean-biomedical-inc-5980949)
- 2025-04-01 20:05 UTC [SEC Form 8-K] [Ocean Biomedical Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/ocean-biomedical-inc-filed-sec-form-8-k-submission-of-matters-5969598)
- 2025-04-01 17:39 UTC [SEC Form NT 10-K filed by Ocean Biomedical Inc.](https://www.quantisnow.com/insight/sec-form-nt-10-k-filed-by-ocean-biomedical-inc-5969286)
- 2025-03-28 12:30 UTC [Ocean Biomedical Announces Grant on Patent Right for Bispecific Antibodies Targeting CHI3L1 and PD1 for Enhanced Tumor Cell Cytotoxicity in China](https://www.quantisnow.com/insight/ocean-biomedical-announces-grant-on-patent-right-for-bispecific-antibodies-5964251)
- 2025-03-26 20:10 UTC [SEC Form 8-K] [Ocean Biomedical Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/ocean-biomedical-inc-filed-sec-form-8-k-other-events-5961116)
- 2025-03-20 20:55 UTC [SEC Form 8-K] [Ocean Biomedical Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/ocean-biomedical-inc-filed-sec-form-8-k-notice-of-delisting-5954763)
- 2025-03-10 20:32 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Ocean Biomedical Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-ocean-biomedical-inc-5936147)
- 2025-03-10 20:30 UTC [SEC Form 8-K] [Ocean Biomedical Inc. filed SEC Form 8-K: Leadership Update](https://www.quantisnow.com/insight/ocean-biomedical-inc-filed-sec-form-8-k-leadership-update-5936099)
- 2025-02-26 22:20 UTC [SEC Form 8-K] [Ocean Biomedical Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits](https://www.quantisnow.com/insight/ocean-biomedical-inc-filed-sec-form-8-k-unregistered-sales-of-5912144)
- 2025-02-26 13:30 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Ocean Biomedical Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-ocean-biomedical-inc-5910459)
- 2025-02-21 22:25 UTC [SEC Form 8-K] [Ocean Biomedical Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year](https://www.quantisnow.com/insight/ocean-biomedical-inc-filed-sec-form-8-k-amendments-to-articles-5903572)
- 2025-02-14 22:27 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by Ocean Biomedical Inc.](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-ocean-biomedical-inc-5891835)
- 2025-02-13 18:11 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Ocean Biomedical Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-ocean-biomedical-inc-5886961)
- 2025-02-12 22:20 UTC [SEC Form 8-K] [Ocean Biomedical Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Other Events](https://www.quantisnow.com/insight/ocean-biomedical-inc-filed-sec-form-8-k-unregistered-sales-of-5885441)
- 2025-02-10 13:00 UTC [Ocean Biomedical Announces Breakthrough Findings in EGFR-Mutant Lung Cancer and Plans for FDA Alignment on Next-Stage Development](https://www.quantisnow.com/insight/ocean-biomedical-announces-breakthrough-findings-in-egfr-mutant-lung-cancer-and-5878848)
- 2025-01-29 13:30 UTC [Ocean Biomedical Advances Malaria Vaccine Research with New NIH Funding and Expedited Development Pathway](https://www.quantisnow.com/insight/ocean-biomedical-advances-malaria-vaccine-research-with-new-nih-funding-5860985)
- 2025-01-13 14:20 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Ocean Biomedical Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-ocean-biomedical-inc-5843636)
- 2024-12-23 12:51 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Ocean Biomedical Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-ocean-biomedical-inc-5823194)
- 2024-12-23 12:50 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Ocean Biomedical Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-ocean-biomedical-inc-5823193)
- 2024-12-17 21:30 UTC [SEC Form 8-K] [SEC Form 8-K filed by Ocean Biomedical Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-ocean-biomedical-inc-5817028)
- 2024-12-11 21:46 UTC [SEC Form 8-K] [Ocean Biomedical Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/ocean-biomedical-inc-filed-sec-form-8-k-notice-of-delisting-5809662)
- 2024-12-09 21:30 UTC [SEC Form 8-K] [Ocean Biomedical Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/ocean-biomedical-inc-filed-sec-form-8-k-notice-of-delisting-5805723)
- 2024-12-06 21:45 UTC [SEC Form 8-K] [Ocean Biomedical Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits](https://www.quantisnow.com/insight/ocean-biomedical-inc-filed-sec-form-8-k-changes-in-registrants-5803991)
- 2024-11-25 22:29 UTC [SEC Form 10-K] [SEC Form 10-K filed by Ocean Biomedical Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-ocean-biomedical-inc-5790717)
- 2024-11-22 21:45 UTC [SEC Form 8-K] [Ocean Biomedical Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/ocean-biomedical-inc-filed-sec-form-8-k-notice-of-delisting-5788733)
- 2024-11-22 21:45 UTC [Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q](https://www.quantisnow.com/insight/ocean-biomedical-inc-announces-receipt-of-notice-from-nasdaq-regarding-5788730)
- 2024-10-29 20:45 UTC [SEC Form 8-K] [Ocean Biomedical Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/ocean-biomedical-inc-filed-sec-form-8-k-leadership-update-financial-5742121)
- 2024-10-22 20:45 UTC [SEC Form 8-K] [Ocean Biomedical Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits](https://www.quantisnow.com/insight/ocean-biomedical-inc-filed-sec-form-8-k-notice-of-delisting-5733690)
- 2024-10-22 20:45 UTC [Ocean Biomedical, Inc. Announces Receipt of Nasdaq Staff Determination Letter](https://www.quantisnow.com/insight/ocean-biomedical-inc-announces-receipt-of-nasdaq-staff-determination-letter-5733683)
- 2024-10-17 21:06 UTC [SEC Form 8-K] [Ocean Biomedical Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits](https://www.quantisnow.com/insight/ocean-biomedical-inc-filed-sec-form-8-k-entry-into-a-5729486)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/OCEA
- Earnings history: https://www.quantisnow.com/earnings/OCEA
- Dividend history: https://www.quantisnow.com/dividends/OCEA
- Insider transactions: https://www.quantisnow.com/insiders/OCEA
- Options chain: https://www.quantisnow.com/options/OCEA
- SEC 8-K filings only: https://www.quantisnow.com/company/OCEA/8-k
- RSS and alerts for OCEA: https://www.quantisnow.com/docs/rss-feeds.md
